NCX-4016 NicOx SA

IDrugs

Volumn 1, Issue 2, 1998, Pages 228-231

  Huizinga, Tom W J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345311891     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Effects of a new class of NO-releasing NSAIDs on platelets and isolated arteries. Minuz P, Lechi C, Bonapace S, Gaino S, Adami A, Cuzzolin L, Del Soldato P, Benoni G INFLAMMOPHARMACOLOGY 1996 4 1 83-90
2. 2 production in rats. Cuzzolin L, Adami A, Degan M, Crivellente F, Bonapace S, Minuz P, Benoni G LIFE SCI 1996 58 11 PL207-PL210
3. NiCox files. NiCox PRESS RELEASE 1996 June 12
4. NicOx products enter phase I trials. SCRIP 1996 2171 11 224276 NO-NSAID: A new class of Gl-sparing nonsteroidal anti-inflammatory drugs. Cirino G, Del Soldato P, Robinson B, Wallace JL INT CONGR INFLAMM RES ASSOC 1996 8th Hershey, PA Abs P70
5. 2 production. Lechi C, Andrioli G, Gaino S, Tommasoli R, Zuliani V, Ortolani R, Degan M, Benoni G, Bellavite P, Lechi A, Minuz P THROMB HAEMOST 1996 76 5 791-798
6. In vitro study of the anti-aggregating activity of two nitroderivatives of acetylsalicylic acid. Lechi C, Gaino S, Tommasoli R, Zuliani V, Bonapace S, Fontana L, Degan M, Lechi A, Minuz P BLOOD COAGUL FIBRINOLYSIS 1996 7 2 206-209
7. Pharmacokinetics of a new nitroderivative of acetylsalicylic acid after a single dose in rats. Tagliaro F, Cuzzolin L, Adami A, Scarcella D, Crivellente F, Benoni G LIFE SCI 1997 60 2 101-106
8. Symposium on 'Newer, Safer NSAIDs' held in conjunction with Digestive Disease Week. Washington DC, USA. IDDB MEETING REPORT 1997 10-14 May
9. Nitric oxide-releasing non-steroidal anti-inflammatory drugs: A new generation of antithrombotics? Wallace JL, Del Soldato P, Cirino G EXP OPIN INVEST DRUGS 1997 6 5 533-538
10. Gastric protection from hemorrhagic shock-induced damage by a nitric oxide-releasing aspirin derivative (NCX 4016). Wallace JL, McKnight W, Wilson TL, Del Soldato P, Cirino G GASTROENTEROLOGY 1997 112 4 Suppl A417
11. Nitric oxide-releasing aspirin derivative (NCX 4016): A gastric-sparing anti-thrombotic drug. Wallace JL, McKnight W, Wilson TL, Cirino G, Del Soldato P, Davies NM GASTROENTEROLOGY 1997 1124 Suppl A325
12. Erratum: Antiaggregating and vasodilatory effects of a new nitroderivative of acetylsalicylic acid (Thrombosis Research 80, no. 5, pp. 367-376, 1995). Minuz P, Lechi C, Tommasoli R, Gaino S, Degan M, Zuliani V, Bonapace S, Benoni G, Adami A, Cuzzolin L, Lechi A THROMB RES 1996 81 2 289-291
13. Antiaggregating and vasodilatory effects of a new nitroderivative of acetylsalicylic acid. Minuz P, Lechi C, Tommasoli R, Gaino S, Degan M, Zuliani V, Bonapace S, Benoni G, Adami A, Cuzzolin L, et al THROMB RES 1995 80 5 367-376
14. Antiaggregating and vasodilatory effects of a new nitroderivative of acetylsalicylic acid. Lechi C, Minuz P, Gaino S, Tommasoli R, Del Soldato P, Benoni G, Zuliani V, Lechi A EUR J CLIN INVEST 1995 25 Suppl 2 A41
15. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative. Wallace JL, McKnight W, Del Soldato P, Baydoun AR, Cirino G J CLIN INVEST 1995 96 6 2711-2718
16. Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal anti-inflammatory derivatives with gastrointestinal-sparing properties. Cirino G, Wheeler Jones CP, Wallace JL, Del Soldato P, Baydoun AR BR J PHARMACOL 1996 117 7 1421-1426
17. Nitric oxide-releasing NSAIDs as a potential treatment for rheumatoid arthritis. Wallace JL, Del Soldato P, Cirino G RHEUMATOID ARTHRITIS ID RESEARCH ALERT 1997 1 1 3-6
18. NicOx raises extra funds. SCRIP 1997 2295 8
19. NCX-4016. DRUGS FUTURE 1997 22 11 1231-1233
20. NeoPharm Inc announces James Hussey has begun as Chief Executive Officer, President and Director/John Kapoor steps down as interim Chief Executive Officer and retains position as Chairman of the Board. NeoPharm Inc (US) PRESS RELEASE 1998 March 17
21. NicOx to research "nitro-aspirins" with Bayer. SCRIP 1998 2317 10
22. Reduction of shock-induced gastric damage by a nitric oxide-releasing aspirin derivative: Role of neutrophils. Wallace JL, McKnight W, Wilson TL, Del Soldato P, Cirino G AM J PHYSIOL GASTROINTEST LIVER PHYSIOL 1997 273 6 36-6 G1246-G-251